SESSION 10
Primary and adjuvant systemic therapy of early breast cancer II

Chairs: Olivia Pagani (Switzerland), Kathleen Pritchard (Canada)

De-escalating and escalating treatment in patients with HER2 positive breast cancer?

 Webcast from Heikki Joensuu, Finland not available

De-escalating and escalating treatment in patients with triple negative breast cancer: Maintenance and post-neoadjuvant setting

 Lisa Carey, USA

De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer

Angelo Di Leo, Italy

 Role of bisphosphonates and denosumab in the adjuvant setting

 Michael Gnant, Austria

Discussion